Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06495684 · ClinicalTrials.gov registry record · NA

Effects of Multiple-Session Transcranial Direct Current Stimulation (tDCS) on Behavioral, Physiological, and Electrophysiological Measures With Adults With Autism Spectrum Disorder (ASD)

A NA study of Autism Spectrum Disorder and Autism or Autistic Traits, sponsored by University of New Mexi.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06495684: Recruiting NA study of Autism Spectrum Disorder and Autism or Autistic Traits, sponsored by University of New Mexi.

NCT06495684 is a NA study of Autism Spectrum Disorder and Autism or Autistic Traits that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 20 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06495684, a NA study of Autism Spectrum Disorder and Autism or Autistic Traits, is actively recruiting participants, sponsored by University of New Mexi.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to investigate the effects of multiple sessions of transcranial direct current stimulation (tDCS) delivered while participants complete tasks that target social learning with high functioning adults with ASD and/or high traits of ASD. The main question it aims to answer is: What are the effects of multiple sessions of active compared to sham tDCS, with tDCS simultaneously paired with social learning tasks, from employing a within-subject, cross-over randomized controlled trial design? Participants will: * Complete a randomly assigned block of 5 sessions of active and a block of 5 sessions of sham tDCS, with a four-week break occurring between the two blocks. * Complete social learning tasks simultaneously during receipt of tDCS at each session (whether receiving active or sham tDCS). * Complete behavioral, physiological, and electrophysiological testing before and after each block of active or sham tDCS. * Complete a social validity questionnaire after completion of the study.

Primary Outcome

Patient-Reported Outcomes Measurement Information System (PROMIS) Item Bank v. 1.0 - Emotional Distress - Anxiety (PEDA) A change in PEDA scores corresponds to a change in emotional distress and anxiety. Each question on the PEDA provides a 5-point scale where lower scores mean a better outcome.

Interventions

  • DEVICE Anodal tDCS + Social Learning
  • BEHAVIORAL Placebo Anodal tDCS + Social Learning

Study Locations (1)

New Mexico

  • University of New Mexico - Albuquerque

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-03-12
Est. Completion 2027-06-30
Phase NA
University of New Mexi

76 total trials

What NCT06495684 shows while recruiting

NCT06495684 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (85% lower).

The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Anodal tDCS + Social Learning is the first listed.

NCT06495684 reports a single indexed study location in New Mexico.

Frequently Asked Questions

What is clinical trial NCT06495684 about?

NCT06495684 is a clinical study titled "Effects of Multiple-Session Transcranial Direct Current Stimulation (tDCS) on Behavioral, Physiological, and Electrophysiological Measures With Adults With Autism Spectrum Disorder (ASD)". The purpose of this clinical trial is to investigate the effects of multiple sessions of transcranial direct current stimulation (tDCS) delivered while participants complete tasks that target social learning with high functioning adults with ASD and/or high traits of ASD. The main question it aims ...

What is the current status of trial NCT06495684?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-12. Estimated completion is 2027-06-30.

What conditions does trial NCT06495684 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder, Autism or Autistic Traits.

What interventions are being tested in trial NCT06495684?

The interventions under investigation include: Anodal tDCS + Social Learning (DEVICE), Placebo Anodal tDCS + Social Learning (BEHAVIORAL).

Who is sponsoring clinical trial NCT06495684?

This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06495684 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06495684's enrollment target sits among peer trials

20 200th of 224 higher than 23 of 224 other Autism Spectrum Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06495684, the US trial registry maintained by the National Library of Medicine. NCT06495684 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.